

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 7.75564782 |
| 2 | attachment of spindle microtubules to kinetochore (GO:0008608) | 7.52972453 |
| 3 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 7.07298078 |
| 4 | regulation of translation, ncRNA-mediated (GO:0045974) | 7.07298078 |
| 5 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 7.07298078 |
| 6 | N-acetylneuraminate metabolic process (GO:0006054) | 6.64150741 |
| 7 | amino sugar catabolic process (GO:0046348) | 6.54525721 |
| 8 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.76534893 |
| 9 | GMP metabolic process (GO:0046037) | 5.28834425 |
| 10 | mitotic metaphase plate congression (GO:0007080) | 5.25325387 |
| 11 | DNA deamination (GO:0045006) | 5.15919600 |
| 12 | negative regulation of myotube differentiation (GO:0010832) | 5.11960433 |
| 13 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 5.10078529 |
| 14 | nuclear pore organization (GO:0006999) | 4.85946468 |
| 15 | facial nerve structural organization (GO:0021612) | 4.63072624 |
| 16 | androgen biosynthetic process (GO:0006702) | 4.52251598 |
| 17 | GDP-mannose metabolic process (GO:0019673) | 4.50893208 |
| 18 | respiratory chain complex IV assembly (GO:0008535) | 4.49472763 |
| 19 | postsynaptic membrane organization (GO:0001941) | 4.37247811 |
| 20 | mannosylation (GO:0097502) | 4.35046973 |
| 21 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 4.28629015 |
| 22 | microtubule anchoring (GO:0034453) | 4.28386229 |
| 23 | metaphase plate congression (GO:0051310) | 4.23768974 |
| 24 | motile cilium assembly (GO:0044458) | 4.20184140 |
| 25 | nerve growth factor signaling pathway (GO:0038180) | 4.18735445 |
| 26 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 4.13069051 |
| 27 | DNA integration (GO:0015074) | 4.13050212 |
| 28 | lymphoid progenitor cell differentiation (GO:0002320) | 3.96086468 |
| 29 | neural tube formation (GO:0001841) | 3.94890803 |
| 30 | presynaptic membrane assembly (GO:0097105) | 3.93003984 |
| 31 | C-terminal protein lipidation (GO:0006501) | 3.87065462 |
| 32 | generation of neurons (GO:0048699) | 3.82236148 |
| 33 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.82184650 |
| 34 | DNA ligation (GO:0006266) | 3.79515223 |
| 35 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.76896868 |
| 36 | heart process (GO:0003015) | 3.70592628 |
| 37 | heart contraction (GO:0060047) | 3.70592628 |
| 38 | cytochrome complex assembly (GO:0017004) | 3.65395995 |
| 39 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.64015347 |
| 40 | regulation of pigment cell differentiation (GO:0050932) | 3.63860719 |
| 41 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.62169943 |
| 42 | C-terminal protein amino acid modification (GO:0018410) | 3.61824822 |
| 43 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 3.61288625 |
| 44 | cranial nerve morphogenesis (GO:0021602) | 3.57311463 |
| 45 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.47149969 |
| 46 | signal peptide processing (GO:0006465) | 3.45025210 |
| 47 | adaptation of signaling pathway (GO:0023058) | 3.44137152 |
| 48 | piRNA metabolic process (GO:0034587) | 3.44060336 |
| 49 | N-acetylglucosamine metabolic process (GO:0006044) | 3.43708084 |
| 50 | viral genome replication (GO:0019079) | 3.40147084 |
| 51 | GPI anchor biosynthetic process (GO:0006506) | 3.37931275 |
| 52 | behavioral response to nicotine (GO:0035095) | 3.33501455 |
| 53 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.29924092 |
| 54 | protein K11-linked deubiquitination (GO:0035871) | 3.29625682 |
| 55 | response to folic acid (GO:0051593) | 3.29334609 |
| 56 | protein heterotetramerization (GO:0051290) | 3.28935162 |
| 57 | cranial nerve structural organization (GO:0021604) | 3.28693951 |
| 58 | histone H2A acetylation (GO:0043968) | 3.28521796 |
| 59 | telomere maintenance via recombination (GO:0000722) | 3.21730745 |
| 60 | proteasome assembly (GO:0043248) | 3.19679413 |
| 61 | mitochondrion degradation (GO:0000422) | 3.16329380 |
| 62 | glycosphingolipid biosynthetic process (GO:0006688) | 3.11828807 |
| 63 | gamma-aminobutyric acid transport (GO:0015812) | 3.11215601 |
| 64 | nephron tubule formation (GO:0072079) | 3.11131723 |
| 65 | tRNA methylation (GO:0030488) | 3.09308550 |
| 66 | presynaptic membrane organization (GO:0097090) | 3.07787515 |
| 67 | DNA dealkylation (GO:0035510) | 3.06976383 |
| 68 | DNA double-strand break processing (GO:0000729) | 3.06517672 |
| 69 | intraciliary transport (GO:0042073) | 3.03106038 |
| 70 | DNA damage response, detection of DNA damage (GO:0042769) | 3.02634108 |
| 71 | negative regulation of metanephros development (GO:0072217) | 2.99897755 |
| 72 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.99302410 |
| 73 | amine catabolic process (GO:0009310) | 2.98131636 |
| 74 | cellular biogenic amine catabolic process (GO:0042402) | 2.98131636 |
| 75 | neuron cell-cell adhesion (GO:0007158) | 2.94776648 |
| 76 | developmental pigmentation (GO:0048066) | 2.94107068 |
| 77 | regulation of cilium movement (GO:0003352) | 2.92754523 |
| 78 | DNA demethylation (GO:0080111) | 2.91497764 |
| 79 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.90859356 |
| 80 | pattern specification involved in kidney development (GO:0061004) | 2.88229714 |
| 81 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.86584988 |
| 82 | centriole assembly (GO:0098534) | 2.86580796 |
| 83 | negative regulation of heart rate (GO:0010459) | 2.86468960 |
| 84 | establishment of integrated proviral latency (GO:0075713) | 2.85033713 |
| 85 | nucleobase catabolic process (GO:0046113) | 2.84315748 |
| 86 | intra-S DNA damage checkpoint (GO:0031573) | 2.82831854 |
| 87 | endothelium development (GO:0003158) | 2.82520650 |
| 88 | neuronal action potential propagation (GO:0019227) | 2.82293787 |
| 89 | sympathetic nervous system development (GO:0048485) | 2.81937983 |
| 90 | methionine biosynthetic process (GO:0009086) | 2.81485921 |
| 91 | cAMP catabolic process (GO:0006198) | 2.80994845 |
| 92 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.80683402 |
| 93 | mesonephros development (GO:0001823) | 2.80633033 |
| 94 | GPI anchor metabolic process (GO:0006505) | 2.80558696 |
| 95 | positive regulation of protein homodimerization activity (GO:0090073) | 2.78066380 |
| 96 | termination of RNA polymerase III transcription (GO:0006386) | 2.77031605 |
| 97 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.77031605 |
| 98 | glucosamine-containing compound metabolic process (GO:1901071) | 2.76660860 |
| 99 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.75188588 |
| 100 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.74621365 |
| 101 | platelet dense granule organization (GO:0060155) | 2.74422896 |
| 102 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.73655234 |
| 103 | membrane invagination (GO:0010324) | 2.72248823 |
| 104 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.72028107 |
| 105 | negative regulation of telomere maintenance (GO:0032205) | 2.71725787 |
| 106 | axoneme assembly (GO:0035082) | 2.70535739 |
| 107 | nonmotile primary cilium assembly (GO:0035058) | 2.69411646 |
| 108 | lateral ventricle development (GO:0021670) | 2.68741982 |
| 109 | spinal cord motor neuron differentiation (GO:0021522) | 2.68567961 |
| 110 | cilium morphogenesis (GO:0060271) | 2.67651863 |
| 111 | imidazole-containing compound metabolic process (GO:0052803) | 2.66986861 |
| 112 | spliceosomal snRNP assembly (GO:0000387) | 2.66765597 |
| 113 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.66613970 |
| 114 | cyclic nucleotide catabolic process (GO:0009214) | 2.65299010 |
| 115 | cell differentiation involved in metanephros development (GO:0072202) | 2.64349124 |
| 116 | limb bud formation (GO:0060174) | 2.64023672 |
| 117 | mitotic recombination (GO:0006312) | 2.63780758 |
| 118 | protein localization to cilium (GO:0061512) | 2.62354214 |
| 119 | DNA replication initiation (GO:0006270) | 2.61824825 |
| 120 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.61238542 |
| 121 | histone mRNA metabolic process (GO:0008334) | 2.61049249 |
| 122 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.60339223 |
| 123 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.59867999 |
| 124 | protein-cofactor linkage (GO:0018065) | 2.59853440 |
| 125 | phospholipid scrambling (GO:0017121) | 2.58104314 |
| 126 | urogenital system development (GO:0001655) | 2.58035874 |
| 127 | establishment of chromosome localization (GO:0051303) | 2.57593026 |
| 128 | cilium assembly (GO:0042384) | 2.57260086 |
| 129 | regulation of relaxation of muscle (GO:1901077) | 2.57151562 |
| 130 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.56741912 |
| 131 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.55913327 |
| 132 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.55913327 |
| 133 | melanin metabolic process (GO:0006582) | 2.55522260 |
| 134 | cilium organization (GO:0044782) | 2.55471356 |
| 135 | central nervous system neuron axonogenesis (GO:0021955) | 2.55191191 |
| 136 | ribosomal small subunit assembly (GO:0000028) | 2.54455971 |
| 137 | carbohydrate phosphorylation (GO:0046835) | 2.53065555 |
| 138 | DNA strand elongation (GO:0022616) | 2.52536920 |
| 139 | sequestering of metal ion (GO:0051238) | 2.51461939 |
| 140 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.50951057 |
| 141 | protein localization to synapse (GO:0035418) | 2.50665178 |
| 142 | sterol biosynthetic process (GO:0016126) | 2.50026932 |
| 143 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.49629763 |
| 144 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.49629763 |
| 145 | telomere maintenance via telomere lengthening (GO:0010833) | 2.49495903 |
| 146 | nephron epithelium development (GO:0072009) | 2.49490686 |
| 147 | negative regulation of meiosis (GO:0045835) | 2.49380161 |
| 148 | synaptic transmission, cholinergic (GO:0007271) | 2.48997920 |
| 149 | glial cell proliferation (GO:0014009) | 2.48641166 |
| 150 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.48384307 |
| 151 | specification of organ identity (GO:0010092) | 2.48172189 |
| 152 | genitalia morphogenesis (GO:0035112) | 2.48019571 |
| 153 | neuroepithelial cell differentiation (GO:0060563) | 2.47552297 |
| 154 | establishment of viral latency (GO:0019043) | 2.47343219 |
| 155 | centriole replication (GO:0007099) | 2.46847028 |
| 156 | glandular epithelial cell differentiation (GO:0002067) | 2.46555727 |
| 157 | ubiquinone metabolic process (GO:0006743) | 2.45680164 |
| 158 | positive regulation of mitochondrial fission (GO:0090141) | 2.45063737 |
| 159 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.44962792 |
| 160 | positive regulation of protein export from nucleus (GO:0046827) | 2.44781798 |
| 161 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.44722464 |
| 162 | cullin deneddylation (GO:0010388) | 2.44688139 |
| 163 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.44671778 |
| 164 | methionine metabolic process (GO:0006555) | 2.44517335 |
| 165 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.43716366 |
| 166 | protein peptidyl-prolyl isomerization (GO:0000413) | 2.43502241 |
| 167 | fucosylation (GO:0036065) | 2.43173023 |
| 168 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.42979993 |
| 169 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.42678780 |
| 170 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.42670165 |
| 171 | dendrite morphogenesis (GO:0048813) | 2.42074451 |
| 172 | protein polyglutamylation (GO:0018095) | 2.40991153 |
| 173 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.40773639 |
| 174 | protein complex biogenesis (GO:0070271) | 2.40663540 |
| 175 | cholesterol biosynthetic process (GO:0006695) | 2.40261305 |
| 176 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.40043203 |
| 177 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.39689711 |
| 178 | peptidyl-cysteine modification (GO:0018198) | 2.39074320 |
| 179 | epithelial cilium movement (GO:0003351) | 2.37475994 |
| 180 | establishment of mitochondrion localization (GO:0051654) | 2.35831542 |
| 181 | peptidyl-histidine modification (GO:0018202) | 2.35789580 |
| 182 | histone mRNA catabolic process (GO:0071044) | 2.33595669 |
| 183 | coenzyme A metabolic process (GO:0015936) | 2.30013101 |
| 184 | regulation of development, heterochronic (GO:0040034) | 2.29718671 |
| 185 | DNA methylation involved in gamete generation (GO:0043046) | 2.29465915 |
| 186 | behavioral fear response (GO:0001662) | 2.28018844 |
| 187 | behavioral defense response (GO:0002209) | 2.28018844 |
| 188 | regulation of DNA endoreduplication (GO:0032875) | 2.27485505 |
| 189 | neuron recognition (GO:0008038) | 2.26873805 |
| 190 | synapse assembly (GO:0007416) | 2.26295456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 8.96782896 |
| 2 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 5.03206867 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.76237798 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.64528866 |
| 5 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.15166120 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.98294393 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.92046289 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.79750130 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.64917824 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.32852411 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.28703204 |
| 12 | EWS_26573619_Chip-Seq_HEK293_Human | 2.21858005 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.17418303 |
| 14 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15799759 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.02152014 |
| 16 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.01274615 |
| 17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.99963607 |
| 18 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.95713270 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93968113 |
| 20 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.93528235 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.91100819 |
| 22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.86156533 |
| 23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84656598 |
| 24 | P300_19829295_ChIP-Seq_ESCs_Human | 1.78129525 |
| 25 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.77424175 |
| 26 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.76910809 |
| 27 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.75734017 |
| 28 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.75025789 |
| 29 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.74911850 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.74885797 |
| 31 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.74642747 |
| 32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.71491231 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.71459376 |
| 34 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69426708 |
| 35 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.69225944 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68768606 |
| 37 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.67380946 |
| 38 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.64927139 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62260220 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60102067 |
| 41 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.60018978 |
| 42 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.59925020 |
| 43 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59583523 |
| 44 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.56135781 |
| 45 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.53980891 |
| 46 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.50808621 |
| 47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50509112 |
| 48 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.48286904 |
| 49 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.48079499 |
| 50 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.48060907 |
| 51 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.47035228 |
| 52 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44469189 |
| 53 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.41879750 |
| 54 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.41396191 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.40099577 |
| 56 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.38434216 |
| 57 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.37480764 |
| 58 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.36700307 |
| 59 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.36254992 |
| 60 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.36254992 |
| 61 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.35490339 |
| 62 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.35367933 |
| 63 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.32813922 |
| 64 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.31857427 |
| 65 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.30322747 |
| 66 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.30173247 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28947184 |
| 68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28784036 |
| 69 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.27501504 |
| 70 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.27291576 |
| 71 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27291576 |
| 72 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.27175756 |
| 73 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.27136945 |
| 74 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.26904383 |
| 75 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.26443903 |
| 76 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.25585713 |
| 77 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.24896180 |
| 78 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.24802005 |
| 79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24727354 |
| 80 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.24367900 |
| 81 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24058456 |
| 82 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.21534193 |
| 83 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.21441275 |
| 84 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.21006892 |
| 85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.19605323 |
| 86 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.18604655 |
| 87 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.18536924 |
| 88 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.18264815 |
| 89 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18019623 |
| 90 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.17792998 |
| 91 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.17694528 |
| 92 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17198501 |
| 93 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.16892603 |
| 94 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.16782695 |
| 95 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16615959 |
| 96 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.14529526 |
| 97 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.14526646 |
| 98 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13799272 |
| 99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13639941 |
| 100 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.13447216 |
| 101 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.13270345 |
| 102 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12765605 |
| 103 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12708010 |
| 104 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.11499814 |
| 105 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.11167683 |
| 106 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.10529669 |
| 107 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09983758 |
| 108 | * GATA3_21867929_ChIP-Seq_CD8_Mouse | 1.09856815 |
| 109 | NCOR_22424771_ChIP-Seq_293T_Human | 1.09042120 |
| 110 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.08202385 |
| 111 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08136685 |
| 112 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.07950403 |
| 113 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07142238 |
| 114 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.06145687 |
| 115 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.05082530 |
| 116 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04449062 |
| 117 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.04301217 |
| 118 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.03597732 |
| 119 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.03349561 |
| 120 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.03346426 |
| 121 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02186892 |
| 122 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.01132883 |
| 123 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.00690291 |
| 124 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99442164 |
| 125 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99027331 |
| 126 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.99026029 |
| 127 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98844880 |
| 128 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98811585 |
| 129 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.98803709 |
| 130 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.98708692 |
| 131 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.98225968 |
| 132 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.96814784 |
| 133 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96572451 |
| 134 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.96566969 |
| 135 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.95751508 |
| 136 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.94975557 |
| 137 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.94340749 |
| 138 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94004157 |
| 139 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.93561518 |
| 140 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92573939 |
| 141 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.92554728 |
| 142 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.92531752 |
| 143 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.92304475 |
| 144 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.92257182 |
| 145 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.92176649 |
| 146 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.90927063 |
| 147 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.90910433 |
| 148 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.90909007 |
| 149 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.90611352 |
| 150 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.89624848 |
| 151 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.89463147 |
| 152 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89354335 |
| 153 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.89130650 |
| 154 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.88543495 |
| 155 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.88543495 |
| 156 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.88357901 |
| 157 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.88077439 |
| 158 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.87671735 |
| 159 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.87594225 |
| 160 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.86055371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005409_darkened_coat_color | 4.60246004 |
| 2 | MP0006292_abnormal_olfactory_placode | 4.51180797 |
| 3 | MP0001188_hyperpigmentation | 4.40374459 |
| 4 | MP0003136_yellow_coat_color | 4.26996438 |
| 5 | MP0001529_abnormal_vocalization | 3.83147382 |
| 6 | MP0000015_abnormal_ear_pigmentation | 3.57619001 |
| 7 | MP0009379_abnormal_foot_pigmentation | 3.54651220 |
| 8 | MP0001986_abnormal_taste_sensitivity | 3.51075729 |
| 9 | MP0005174_abnormal_tail_pigmentation | 3.18542890 |
| 10 | MP0002876_abnormal_thyroid_physiology | 3.00225945 |
| 11 | MP0008260_abnormal_autophagy | 2.97174936 |
| 12 | MP0000372_irregular_coat_pigmentation | 2.74918270 |
| 13 | MP0004270_analgesia | 2.68834575 |
| 14 | MP0005075_abnormal_melanosome_morpholog | 2.28705633 |
| 15 | MP0003011_delayed_dark_adaptation | 2.16670482 |
| 16 | MP0003724_increased_susceptibility_to | 2.07646609 |
| 17 | MP0002638_abnormal_pupillary_reflex | 2.07370787 |
| 18 | MP0002095_abnormal_skin_pigmentation | 2.06871742 |
| 19 | MP0004381_abnormal_hair_follicle | 1.96179538 |
| 20 | MP0002751_abnormal_autonomic_nervous | 1.90768790 |
| 21 | MP0003880_abnormal_central_pattern | 1.87114299 |
| 22 | MP0008058_abnormal_DNA_repair | 1.86362738 |
| 23 | MP0001485_abnormal_pinna_reflex | 1.72956590 |
| 24 | MP0000681_abnormal_thyroid_gland | 1.70653764 |
| 25 | MP0002653_abnormal_ependyma_morphology | 1.66464316 |
| 26 | MP0001984_abnormal_olfaction | 1.65134621 |
| 27 | MP0002736_abnormal_nociception_after | 1.64059457 |
| 28 | MP0002938_white_spotting | 1.63230296 |
| 29 | MP0000678_abnormal_parathyroid_gland | 1.62648177 |
| 30 | MP0003122_maternal_imprinting | 1.59757195 |
| 31 | MP0002233_abnormal_nose_morphology | 1.57845293 |
| 32 | MP0002177_abnormal_outer_ear | 1.56698199 |
| 33 | MP0003718_maternal_effect | 1.53576536 |
| 34 | MP0004145_abnormal_muscle_electrophysio | 1.52405328 |
| 35 | MP0002734_abnormal_mechanical_nocicepti | 1.49681831 |
| 36 | MP0005379_endocrine/exocrine_gland_phen | 1.42884578 |
| 37 | MP0000631_abnormal_neuroendocrine_gland | 1.42750225 |
| 38 | MP0000778_abnormal_nervous_system | 1.41999245 |
| 39 | MP0003868_abnormal_feces_composition | 1.39163732 |
| 40 | MP0001502_abnormal_circadian_rhythm | 1.38137999 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.35034496 |
| 42 | MP0003121_genomic_imprinting | 1.32800424 |
| 43 | MP0002160_abnormal_reproductive_system | 1.31812432 |
| 44 | MP0006276_abnormal_autonomic_nervous | 1.31019628 |
| 45 | MP0009745_abnormal_behavioral_response | 1.30447027 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.30436788 |
| 47 | MP0009046_muscle_twitch | 1.29126084 |
| 48 | MP0003635_abnormal_synaptic_transmissio | 1.27677205 |
| 49 | MP0001944_abnormal_pancreas_morphology | 1.27074234 |
| 50 | MP0002693_abnormal_pancreas_physiology | 1.26253209 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.24894066 |
| 52 | MP0001486_abnormal_startle_reflex | 1.23047951 |
| 53 | MP0005171_absent_coat_pigmentation | 1.22886769 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.19414835 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 1.18450641 |
| 56 | MP0000490_abnormal_crypts_of | 1.18446904 |
| 57 | MP0003879_abnormal_hair_cell | 1.14723165 |
| 58 | MP0001835_abnormal_antigen_presentation | 1.14622220 |
| 59 | MP0008789_abnormal_olfactory_epithelium | 1.13645425 |
| 60 | MP0001186_pigmentation_phenotype | 1.13297724 |
| 61 | MP0002063_abnormal_learning/memory/cond | 1.12466316 |
| 62 | MP0003693_abnormal_embryo_hatching | 1.12411868 |
| 63 | MP0004084_abnormal_cardiac_muscle | 1.09719480 |
| 64 | MP0002075_abnormal_coat/hair_pigmentati | 1.09321369 |
| 65 | MP0000049_abnormal_middle_ear | 1.08950580 |
| 66 | MP0002184_abnormal_innervation | 1.08436400 |
| 67 | MP0000613_abnormal_salivary_gland | 1.07919069 |
| 68 | MP0002822_catalepsy | 1.06818126 |
| 69 | MP0005671_abnormal_response_to | 1.05126881 |
| 70 | MP0000566_synostosis | 1.04951372 |
| 71 | MP0005646_abnormal_pituitary_gland | 1.04889503 |
| 72 | MP0003221_abnormal_cardiomyocyte_apopto | 1.04386732 |
| 73 | MP0002572_abnormal_emotion/affect_behav | 1.02955854 |
| 74 | MP0001849_ear_inflammation | 1.02021869 |
| 75 | MP0004924_abnormal_behavior | 1.00414850 |
| 76 | MP0005386_behavior/neurological_phenoty | 1.00414850 |
| 77 | MP0003786_premature_aging | 0.98880845 |
| 78 | MP0004142_abnormal_muscle_tone | 0.97750989 |
| 79 | MP0004133_heterotaxia | 0.97327563 |
| 80 | MP0004859_abnormal_synaptic_plasticity | 0.97079518 |
| 81 | MP0003283_abnormal_digestive_organ | 0.95768156 |
| 82 | MP0008007_abnormal_cellular_replicative | 0.95504987 |
| 83 | MP0000749_muscle_degeneration | 0.94810196 |
| 84 | MP0002234_abnormal_pharynx_morphology | 0.94282256 |
| 85 | MP0001968_abnormal_touch/_nociception | 0.93216654 |
| 86 | MP0002752_abnormal_somatic_nervous | 0.93195125 |
| 87 | MP0008569_lethality_at_weaning | 0.93069044 |
| 88 | MP0002557_abnormal_social/conspecific_i | 0.93019847 |
| 89 | MP0002396_abnormal_hematopoietic_system | 0.92436551 |
| 90 | MP0003890_abnormal_embryonic-extraembry | 0.91360119 |
| 91 | MP0000371_diluted_coat_color | 0.91304667 |
| 92 | MP0002148_abnormal_hypersensitivity_rea | 0.90973361 |
| 93 | MP0003303_peritoneal_inflammation | 0.90504304 |
| 94 | MP0010386_abnormal_urinary_bladder | 0.90480060 |
| 95 | MP0005499_abnormal_olfactory_system | 0.90027013 |
| 96 | MP0005394_taste/olfaction_phenotype | 0.90027013 |
| 97 | MP0002928_abnormal_bile_duct | 0.89843744 |
| 98 | MP0004811_abnormal_neuron_physiology | 0.89067011 |
| 99 | MP0002163_abnormal_gland_morphology | 0.89005477 |
| 100 | MP0003861_abnormal_nervous_system | 0.88892838 |
| 101 | MP0002882_abnormal_neuron_morphology | 0.88547186 |
| 102 | MP0005391_vision/eye_phenotype | 0.88225460 |
| 103 | MP0003119_abnormal_digestive_system | 0.87654966 |
| 104 | MP0010094_abnormal_chromosome_stability | 0.87626107 |
| 105 | MP0006072_abnormal_retinal_apoptosis | 0.87364185 |
| 106 | MP0009785_altered_susceptibility_to | 0.86708663 |
| 107 | MP0000653_abnormal_sex_gland | 0.85795484 |
| 108 | MP0003646_muscle_fatigue | 0.85231317 |
| 109 | MP0002272_abnormal_nervous_system | 0.83918933 |
| 110 | MP0003755_abnormal_palate_morphology | 0.82456951 |
| 111 | MP0005220_abnormal_exocrine_pancreas | 0.82353584 |
| 112 | MP0000569_abnormal_digit_pigmentation | 0.81997173 |
| 113 | MP0003787_abnormal_imprinting | 0.81448471 |
| 114 | MP0006035_abnormal_mitochondrial_morpho | 0.81342332 |
| 115 | MP0002837_dystrophic_cardiac_calcinosis | 0.80765183 |
| 116 | MP0003698_abnormal_male_reproductive | 0.79966923 |
| 117 | MP0000955_abnormal_spinal_cord | 0.79653120 |
| 118 | MP0002064_seizures | 0.78841462 |
| 119 | MP0001970_abnormal_pain_threshold | 0.78459113 |
| 120 | MP0004742_abnormal_vestibular_system | 0.78346833 |
| 121 | MP0005367_renal/urinary_system_phenotyp | 0.78332372 |
| 122 | MP0000516_abnormal_urinary_system | 0.78332372 |
| 123 | MP0003828_pulmonary_edema | 0.77873753 |
| 124 | MP0000026_abnormal_inner_ear | 0.77533799 |
| 125 | MP0000465_gastrointestinal_hemorrhage | 0.77531875 |
| 126 | MP0002277_abnormal_respiratory_mucosa | 0.76551127 |
| 127 | MP0002067_abnormal_sensory_capabilities | 0.75945556 |
| 128 | MP0001145_abnormal_male_reproductive | 0.75674356 |
| 129 | MP0001286_abnormal_eye_development | 0.75635766 |
| 130 | MP0002152_abnormal_brain_morphology | 0.74998626 |
| 131 | MP0002210_abnormal_sex_determination | 0.74350587 |
| 132 | MP0005423_abnormal_somatic_nervous | 0.73416046 |
| 133 | MP0003938_abnormal_ear_development | 0.73329864 |
| 134 | MP0001929_abnormal_gametogenesis | 0.72958263 |
| 135 | MP0003385_abnormal_body_wall | 0.72398617 |
| 136 | MP0001293_anophthalmia | 0.72302685 |
| 137 | MP0005025_abnormal_response_to | 0.71785733 |
| 138 | MP0001919_abnormal_reproductive_system | 0.70966995 |
| 139 | MP0002069_abnormal_eating/drinking_beha | 0.70787557 |
| 140 | MP0001270_distended_abdomen | 0.70683693 |
| 141 | MP0005645_abnormal_hypothalamus_physiol | 0.70319247 |
| 142 | MP0005000_abnormal_immune_tolerance | 0.70230156 |
| 143 | MP0008995_early_reproductive_senescence | 0.70026482 |
| 144 | MP0002933_joint_inflammation | 0.69665211 |
| 145 | MP0004885_abnormal_endolymph | 0.69650922 |
| 146 | MP0005551_abnormal_eye_electrophysiolog | 0.69398280 |
| 147 | MP0003866_abnormal_defecation | 0.69092105 |
| 148 | MP0002420_abnormal_adaptive_immunity | 0.68771123 |
| 149 | MP0009697_abnormal_copulation | 0.68381368 |
| 150 | MP0008877_abnormal_DNA_methylation | 0.67861832 |
| 151 | MP0005389_reproductive_system_phenotype | 0.67829147 |
| 152 | MP0001819_abnormal_immune_cell | 0.66788916 |
| 153 | MP0002102_abnormal_ear_morphology | 0.66736514 |
| 154 | MP0001905_abnormal_dopamine_level | 0.66274564 |
| 155 | MP0005410_abnormal_fertilization | 0.65592338 |
| 156 | MP0005253_abnormal_eye_physiology | 0.64481502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type I transferrin isoform profile (HP:0003642) | 7.84511661 |
| 2 | Reduced antithrombin III activity (HP:0001976) | 7.41754512 |
| 3 | Abnormal glycosylation (HP:0012345) | 5.53384726 |
| 4 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 5.53384726 |
| 5 | Abnormal protein N-linked glycosylation (HP:0012347) | 5.53384726 |
| 6 | Abnormal protein glycosylation (HP:0012346) | 5.53384726 |
| 7 | Hypothermia (HP:0002045) | 4.76656362 |
| 8 | Thyroid-stimulating hormone excess (HP:0002925) | 4.12682640 |
| 9 | Hypoplasia of the fovea (HP:0007750) | 3.39206569 |
| 10 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.39206569 |
| 11 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.31995112 |
| 12 | Microvesicular hepatic steatosis (HP:0001414) | 3.31536144 |
| 13 | Cholecystitis (HP:0001082) | 3.24740063 |
| 14 | Abnormal gallbladder physiology (HP:0012438) | 3.24740063 |
| 15 | Agitation (HP:0000713) | 3.20856941 |
| 16 | Severe visual impairment (HP:0001141) | 3.19644631 |
| 17 | Attenuation of retinal blood vessels (HP:0007843) | 3.14295955 |
| 18 | Molar tooth sign on MRI (HP:0002419) | 3.11818900 |
| 19 | Abnormality of midbrain morphology (HP:0002418) | 3.11818900 |
| 20 | Shoulder girdle muscle weakness (HP:0003547) | 3.04041886 |
| 21 | Abnormality of the labia minora (HP:0012880) | 3.01404044 |
| 22 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.93852021 |
| 23 | Fetal akinesia sequence (HP:0001989) | 2.91368117 |
| 24 | Abnormality of magnesium homeostasis (HP:0004921) | 2.87568413 |
| 25 | Muscle fiber atrophy (HP:0100295) | 2.87369985 |
| 26 | Cortical visual impairment (HP:0100704) | 2.86937202 |
| 27 | True hermaphroditism (HP:0010459) | 2.86460893 |
| 28 | Broad-based gait (HP:0002136) | 2.84578126 |
| 29 | Thoracic kyphosis (HP:0002942) | 2.83618053 |
| 30 | Nonprogressive disorder (HP:0003680) | 2.81943367 |
| 31 | Abnormality of the fovea (HP:0000493) | 2.77559288 |
| 32 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.76545185 |
| 33 | Sex reversal (HP:0012245) | 2.72821179 |
| 34 | Abnormal sex determination (HP:0012244) | 2.72821179 |
| 35 | Rimmed vacuoles (HP:0003805) | 2.70274830 |
| 36 | Hip dysplasia (HP:0001385) | 2.68275786 |
| 37 | Medial flaring of the eyebrow (HP:0010747) | 2.67393120 |
| 38 | Atonic seizures (HP:0010819) | 2.67342837 |
| 39 | Gait imbalance (HP:0002141) | 2.64356789 |
| 40 | Capillary hemangiomas (HP:0005306) | 2.63609033 |
| 41 | Type II lissencephaly (HP:0007260) | 2.61906986 |
| 42 | Pancreatic fibrosis (HP:0100732) | 2.61092903 |
| 43 | Dry hair (HP:0011359) | 2.59932089 |
| 44 | 3-Methylglutaconic aciduria (HP:0003535) | 2.58973941 |
| 45 | Lower limb hyperreflexia (HP:0002395) | 2.57852792 |
| 46 | Decreased muscle mass (HP:0003199) | 2.53057873 |
| 47 | Aplasia of the musculature (HP:0100854) | 2.51447120 |
| 48 | Ocular albinism (HP:0001107) | 2.50630743 |
| 49 | Limb-girdle muscle atrophy (HP:0003797) | 2.50547044 |
| 50 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.49640747 |
| 51 | Volvulus (HP:0002580) | 2.49589596 |
| 52 | Congenital primary aphakia (HP:0007707) | 2.48718471 |
| 53 | Tubulointerstitial nephritis (HP:0001970) | 2.48063654 |
| 54 | Progressive inability to walk (HP:0002505) | 2.47962808 |
| 55 | Drooling (HP:0002307) | 2.46282694 |
| 56 | Split foot (HP:0001839) | 2.46262080 |
| 57 | Lissencephaly (HP:0001339) | 2.43858430 |
| 58 | Late onset (HP:0003584) | 2.42803087 |
| 59 | Increased hepatocellular lipid droplets (HP:0006565) | 2.42336647 |
| 60 | Renal Fanconi syndrome (HP:0001994) | 2.40280861 |
| 61 | Hyperventilation (HP:0002883) | 2.40183067 |
| 62 | Aplastic anemia (HP:0001915) | 2.37663525 |
| 63 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.37571758 |
| 64 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.37571758 |
| 65 | Nephrogenic diabetes insipidus (HP:0009806) | 2.36246378 |
| 66 | Left ventricular hypertrophy (HP:0001712) | 2.34743917 |
| 67 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.30233820 |
| 68 | Cerebellar dysplasia (HP:0007033) | 2.28823563 |
| 69 | Renal cortical cysts (HP:0000803) | 2.28594422 |
| 70 | Iris hypopigmentation (HP:0007730) | 2.25013616 |
| 71 | Abnormality of the renal cortex (HP:0011035) | 2.24055024 |
| 72 | Hemiplegia (HP:0002301) | 2.23567846 |
| 73 | Absent speech (HP:0001344) | 2.21343250 |
| 74 | Nephronophthisis (HP:0000090) | 2.19953319 |
| 75 | Pendular nystagmus (HP:0012043) | 2.19914764 |
| 76 | Abnormality of secondary sexual hair (HP:0009888) | 2.19510340 |
| 77 | Abnormality of the axillary hair (HP:0100134) | 2.19510340 |
| 78 | Excessive salivation (HP:0003781) | 2.19506832 |
| 79 | Exertional dyspnea (HP:0002875) | 2.18872566 |
| 80 | Pelvic girdle muscle weakness (HP:0003749) | 2.18659305 |
| 81 | Abnormal number of erythroid precursors (HP:0012131) | 2.17785995 |
| 82 | Short tibia (HP:0005736) | 2.17692815 |
| 83 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.16987582 |
| 84 | Abnormality of the columella (HP:0009929) | 2.16498827 |
| 85 | Abnormal biliary tract physiology (HP:0012439) | 2.16071052 |
| 86 | Bile duct proliferation (HP:0001408) | 2.16071052 |
| 87 | Focal motor seizures (HP:0011153) | 2.15274841 |
| 88 | Pancreatic cysts (HP:0001737) | 2.13846834 |
| 89 | Methylmalonic acidemia (HP:0002912) | 2.13820225 |
| 90 | Inability to walk (HP:0002540) | 2.13325237 |
| 91 | Hyperglycinemia (HP:0002154) | 2.12888354 |
| 92 | Hepatocellular necrosis (HP:0001404) | 2.12383282 |
| 93 | Abnormality of the renal medulla (HP:0100957) | 2.12322052 |
| 94 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.12258297 |
| 95 | Abolished electroretinogram (ERG) (HP:0000550) | 2.11077998 |
| 96 | Restlessness (HP:0000711) | 2.10756659 |
| 97 | Abnormality of the preputium (HP:0100587) | 2.10013497 |
| 98 | Sclerocornea (HP:0000647) | 2.09641336 |
| 99 | Genital tract atresia (HP:0001827) | 2.09341600 |
| 100 | Abnormality of placental membranes (HP:0011409) | 2.08022890 |
| 101 | Amniotic constriction ring (HP:0009775) | 2.08022890 |
| 102 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.07028759 |
| 103 | Polyphagia (HP:0002591) | 2.06727755 |
| 104 | Retinal dysplasia (HP:0007973) | 2.06108359 |
| 105 | Infantile muscular hypotonia (HP:0008947) | 2.05534730 |
| 106 | Occipital encephalocele (HP:0002085) | 2.05231057 |
| 107 | Prolonged partial thromboplastin time (HP:0003645) | 2.03951830 |
| 108 | Popliteal pterygium (HP:0009756) | 2.03344730 |
| 109 | Increased corneal curvature (HP:0100692) | 2.02703626 |
| 110 | Keratoconus (HP:0000563) | 2.02703626 |
| 111 | Chorioretinal atrophy (HP:0000533) | 2.02690863 |
| 112 | Cystic liver disease (HP:0006706) | 2.01906423 |
| 113 | Meckel diverticulum (HP:0002245) | 2.01742006 |
| 114 | Vaginal atresia (HP:0000148) | 2.01252826 |
| 115 | Abnormality of the ileum (HP:0001549) | 2.01199606 |
| 116 | Narrow forehead (HP:0000341) | 2.00712816 |
| 117 | Hypoplasia of the pons (HP:0012110) | 2.00449497 |
| 118 | Lipid accumulation in hepatocytes (HP:0006561) | 1.99518085 |
| 119 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.97399081 |
| 120 | Pachygyria (HP:0001302) | 1.96484603 |
| 121 | Hemiparesis (HP:0001269) | 1.96202921 |
| 122 | Bifid tongue (HP:0010297) | 1.95844773 |
| 123 | Hypomagnesemia (HP:0002917) | 1.95712353 |
| 124 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.95675104 |
| 125 | Dyschromatopsia (HP:0007641) | 1.95124260 |
| 126 | Colon cancer (HP:0003003) | 1.94740604 |
| 127 | Hepatic necrosis (HP:0002605) | 1.94651144 |
| 128 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.94370962 |
| 129 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.93962522 |
| 130 | Optic nerve hypoplasia (HP:0000609) | 1.93524060 |
| 131 | Chronic hepatic failure (HP:0100626) | 1.93336518 |
| 132 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.91864849 |
| 133 | Median cleft lip (HP:0000161) | 1.90814558 |
| 134 | Ependymoma (HP:0002888) | 1.90746372 |
| 135 | Broad face (HP:0000283) | 1.90496550 |
| 136 | Flat occiput (HP:0005469) | 1.88453952 |
| 137 | Abnormality of DNA repair (HP:0003254) | 1.88396908 |
| 138 | Abnormality of chromosome stability (HP:0003220) | 1.88364395 |
| 139 | Congenital stationary night blindness (HP:0007642) | 1.87815741 |
| 140 | Optic disc pallor (HP:0000543) | 1.87645394 |
| 141 | Postaxial foot polydactyly (HP:0001830) | 1.86568151 |
| 142 | Poor coordination (HP:0002370) | 1.86352324 |
| 143 | Oculomotor apraxia (HP:0000657) | 1.86281937 |
| 144 | Cortical dysplasia (HP:0002539) | 1.86010667 |
| 145 | Decreased central vision (HP:0007663) | 1.83788984 |
| 146 | Abnormality of the pons (HP:0007361) | 1.82424959 |
| 147 | Abnormality of the prostate (HP:0008775) | 1.82310959 |
| 148 | Small hand (HP:0200055) | 1.81627440 |
| 149 | Postaxial hand polydactyly (HP:0001162) | 1.81364792 |
| 150 | Increased CSF lactate (HP:0002490) | 1.81054712 |
| 151 | Chromsome breakage (HP:0040012) | 1.80208604 |
| 152 | Dandy-Walker malformation (HP:0001305) | 1.78101551 |
| 153 | Abnormal hair whorl (HP:0010721) | 1.77754907 |
| 154 | Intestinal atresia (HP:0011100) | 1.77669282 |
| 155 | Reticulocytopenia (HP:0001896) | 1.77227615 |
| 156 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.76931869 |
| 157 | Acute lymphatic leukemia (HP:0006721) | 1.76708809 |
| 158 | Microcytic anemia (HP:0001935) | 1.76354113 |
| 159 | Supernumerary spleens (HP:0009799) | 1.76282124 |
| 160 | Type 2 muscle fiber atrophy (HP:0003554) | 1.74772140 |
| 161 | Abnormality of renal resorption (HP:0011038) | 1.74382286 |
| 162 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.73651440 |
| 163 | Basal ganglia calcification (HP:0002135) | 1.72370076 |
| 164 | Clubbing of toes (HP:0100760) | 1.70111255 |
| 165 | Mitochondrial inheritance (HP:0001427) | 1.68341023 |
| 166 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.66670484 |
| 167 | Meningitis (HP:0001287) | 1.66495092 |
| 168 | Decreased circulating renin level (HP:0003351) | 1.66333960 |
| 169 | Abnormality of the thoracic spine (HP:0100711) | 1.66052270 |
| 170 | Gaze-evoked nystagmus (HP:0000640) | 1.65496397 |
| 171 | Abnormal spermatogenesis (HP:0008669) | 1.64351196 |
| 172 | Male pseudohermaphroditism (HP:0000037) | 1.64246362 |
| 173 | Patchy hypopigmentation of hair (HP:0011365) | 1.63440053 |
| 174 | Preaxial hand polydactyly (HP:0001177) | 1.63389332 |
| 175 | Progressive muscle weakness (HP:0003323) | 1.62320728 |
| 176 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.62164379 |
| 177 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.62164379 |
| 178 | Renal tubular dysfunction (HP:0000124) | 1.61104770 |
| 179 | Hypoplasia of the radius (HP:0002984) | 1.59247362 |
| 180 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.59195246 |
| 181 | Spinal canal stenosis (HP:0003416) | 1.59002191 |
| 182 | Anencephaly (HP:0002323) | 1.58614086 |
| 183 | Recurrent cutaneous fungal infections (HP:0011370) | 1.57097936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 8.21301462 |
| 2 | NEK1 | 6.71254141 |
| 3 | EIF2AK3 | 5.09103415 |
| 4 | VRK2 | 4.49162947 |
| 5 | MARK1 | 3.18587576 |
| 6 | STK16 | 3.11947272 |
| 7 | NME2 | 3.08686717 |
| 8 | MKNK2 | 3.02111195 |
| 9 | NLK | 2.97969681 |
| 10 | MAPK13 | 2.82901596 |
| 11 | CASK | 2.40609050 |
| 12 | MAP3K4 | 2.40127325 |
| 13 | FRK | 2.24783648 |
| 14 | TEC | 2.14484658 |
| 15 | NUAK1 | 2.12632359 |
| 16 | FES | 2.11491155 |
| 17 | CAMKK2 | 2.05646449 |
| 18 | MAP4K2 | 2.03346144 |
| 19 | MKNK1 | 2.01435613 |
| 20 | SRPK1 | 1.89902852 |
| 21 | MUSK | 1.85440512 |
| 22 | EIF2AK2 | 1.84672188 |
| 23 | IRAK3 | 1.80331433 |
| 24 | BCR | 1.78725810 |
| 25 | IRAK4 | 1.73848349 |
| 26 | TRIM28 | 1.68262085 |
| 27 | TLK1 | 1.59508254 |
| 28 | ZAK | 1.58753529 |
| 29 | MAP2K7 | 1.57674201 |
| 30 | INSRR | 1.53536360 |
| 31 | PRPF4B | 1.44878432 |
| 32 | MAPK15 | 1.42106429 |
| 33 | STK39 | 1.40551334 |
| 34 | CSNK1G2 | 1.35059001 |
| 35 | CAMK1 | 1.32763396 |
| 36 | NTRK3 | 1.30862771 |
| 37 | EPHA3 | 1.22019750 |
| 38 | YES1 | 1.19317930 |
| 39 | VRK1 | 1.17518222 |
| 40 | EPHA4 | 1.17167226 |
| 41 | OXSR1 | 1.14353812 |
| 42 | BTK | 1.13560985 |
| 43 | KIT | 1.13055940 |
| 44 | FLT3 | 1.05176081 |
| 45 | PAK3 | 1.05130855 |
| 46 | STK38L | 1.04648963 |
| 47 | BCKDK | 1.03869178 |
| 48 | BUB1 | 1.02113735 |
| 49 | TSSK6 | 0.99652567 |
| 50 | PLK2 | 0.93895591 |
| 51 | CDK3 | 0.92485372 |
| 52 | PIM2 | 0.91465345 |
| 53 | DYRK3 | 0.89363382 |
| 54 | PASK | 0.88983577 |
| 55 | IRAK1 | 0.88306731 |
| 56 | MAPK11 | 0.83577664 |
| 57 | IRAK2 | 0.82911083 |
| 58 | PRKCE | 0.82417436 |
| 59 | CLK1 | 0.80444452 |
| 60 | SIK3 | 0.80182840 |
| 61 | PRKD2 | 0.80136983 |
| 62 | HIPK2 | 0.77867671 |
| 63 | TAOK2 | 0.77539454 |
| 64 | ADRBK2 | 0.75885529 |
| 65 | WEE1 | 0.74044613 |
| 66 | CDK19 | 0.69544474 |
| 67 | NEK2 | 0.69067416 |
| 68 | PRKCG | 0.68033620 |
| 69 | UHMK1 | 0.66870397 |
| 70 | MAPK12 | 0.63199279 |
| 71 | PLK3 | 0.63032994 |
| 72 | NME1 | 0.62349026 |
| 73 | MINK1 | 0.61928220 |
| 74 | PINK1 | 0.61386552 |
| 75 | WNK4 | 0.61302222 |
| 76 | TXK | 0.61004278 |
| 77 | MAPKAPK3 | 0.60830456 |
| 78 | PKN1 | 0.58538996 |
| 79 | AKT3 | 0.58092238 |
| 80 | BRSK2 | 0.57393464 |
| 81 | CDK8 | 0.55722644 |
| 82 | BMPR1B | 0.55430705 |
| 83 | MARK2 | 0.54118901 |
| 84 | CDC7 | 0.52685543 |
| 85 | BMPR2 | 0.51910682 |
| 86 | MAP3K5 | 0.50791886 |
| 87 | SIK2 | 0.50726014 |
| 88 | MAPKAPK5 | 0.50032674 |
| 89 | PAK6 | 0.49490002 |
| 90 | BRD4 | 0.49393602 |
| 91 | MAP2K4 | 0.49373943 |
| 92 | PIK3CG | 0.49083451 |
| 93 | PNCK | 0.47976927 |
| 94 | LYN | 0.47702836 |
| 95 | PLK4 | 0.47380094 |
| 96 | CAMK4 | 0.47325375 |
| 97 | NTRK2 | 0.47284242 |
| 98 | ERBB3 | 0.45214066 |
| 99 | MAP3K14 | 0.45172093 |
| 100 | PRKACB | 0.43288960 |
| 101 | LIMK1 | 0.43093427 |
| 102 | MAP3K6 | 0.41691968 |
| 103 | MAPK4 | 0.41554531 |
| 104 | CDK5 | 0.39948443 |
| 105 | DAPK1 | 0.39258728 |
| 106 | CDK7 | 0.38445537 |
| 107 | SYK | 0.38379162 |
| 108 | DYRK2 | 0.37814333 |
| 109 | TIE1 | 0.37767134 |
| 110 | CAMK2B | 0.37324667 |
| 111 | PRKCI | 0.36063399 |
| 112 | BRAF | 0.36004426 |
| 113 | WNK3 | 0.35757114 |
| 114 | CSNK2A1 | 0.35487718 |
| 115 | PLK1 | 0.35120286 |
| 116 | CAMK2A | 0.34823276 |
| 117 | CCNB1 | 0.34143339 |
| 118 | CSNK1G1 | 0.34050045 |
| 119 | IKBKB | 0.33647528 |
| 120 | ATR | 0.33391285 |
| 121 | PTK2B | 0.33122245 |
| 122 | ACVR1B | 0.32729809 |
| 123 | FER | 0.32631593 |
| 124 | ZAP70 | 0.31923654 |
| 125 | ATM | 0.31362343 |
| 126 | EIF2AK1 | 0.31085833 |
| 127 | DYRK1A | 0.30436147 |
| 128 | PRKD1 | 0.29668262 |
| 129 | TAF1 | 0.29214639 |
| 130 | OBSCN | 0.28938595 |
| 131 | KSR1 | 0.28618125 |
| 132 | CSK | 0.28298346 |
| 133 | CDK14 | 0.28228697 |
| 134 | SGK2 | 0.28079499 |
| 135 | PHKG2 | 0.27973280 |
| 136 | PHKG1 | 0.27973280 |
| 137 | MAPK9 | 0.27848357 |
| 138 | NEK6 | 0.26638310 |
| 139 | GRK1 | 0.26388434 |
| 140 | RAF1 | 0.26081028 |
| 141 | CSNK1D | 0.25385694 |
| 142 | MAP3K12 | 0.25315987 |
| 143 | AURKB | 0.25164119 |
| 144 | LCK | 0.25138270 |
| 145 | MAP2K6 | 0.25132442 |
| 146 | RPS6KA4 | 0.25011571 |
| 147 | PRKG2 | 0.24802245 |
| 148 | RPS6KA5 | 0.24209761 |
| 149 | CSNK1A1L | 0.23773208 |
| 150 | RIPK4 | 0.23353336 |
| 151 | CSNK1G3 | 0.22986212 |
| 152 | CSF1R | 0.22882836 |
| 153 | MATK | 0.22168754 |
| 154 | RPS6KB1 | 0.20935885 |
| 155 | PRKAA2 | 0.19004039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.72779791 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.35004442 |
| 3 | Homologous recombination_Homo sapiens_hsa03440 | 2.94748995 |
| 4 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.91413901 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.90187434 |
| 6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.84809362 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.71448028 |
| 8 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.64851677 |
| 9 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.58531368 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.42249447 |
| 11 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.40419960 |
| 12 | RNA polymerase_Homo sapiens_hsa03020 | 2.23837348 |
| 13 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.17739486 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.12901475 |
| 15 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.05025602 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.02375641 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 2.00185299 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.98695593 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.95951443 |
| 20 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.82983662 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.80275967 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.79104130 |
| 23 | Purine metabolism_Homo sapiens_hsa00230 | 1.76907775 |
| 24 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.76050671 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.73254218 |
| 26 | Phototransduction_Homo sapiens_hsa04744 | 1.72060846 |
| 27 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.67613949 |
| 28 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.60117190 |
| 29 | Basal transcription factors_Homo sapiens_hsa03022 | 1.59647773 |
| 30 | Thyroid cancer_Homo sapiens_hsa05216 | 1.58460648 |
| 31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.54157945 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.49618836 |
| 33 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.49101130 |
| 34 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.48728401 |
| 35 | Circadian rhythm_Homo sapiens_hsa04710 | 1.43027924 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32525105 |
| 37 | Spliceosome_Homo sapiens_hsa03040 | 1.32168009 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.31400207 |
| 39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.30545008 |
| 40 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.29920682 |
| 41 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.29438951 |
| 42 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.15971228 |
| 43 | RNA degradation_Homo sapiens_hsa03018 | 1.14842055 |
| 44 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.11921434 |
| 45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.09466435 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.09200123 |
| 47 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.08789466 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.08430034 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.08281162 |
| 50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.08089121 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 1.06009465 |
| 52 | Taste transduction_Homo sapiens_hsa04742 | 1.04856285 |
| 53 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.03407672 |
| 54 | Proteasome_Homo sapiens_hsa03050 | 1.01578433 |
| 55 | Nicotine addiction_Homo sapiens_hsa05033 | 1.01190276 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97357328 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96181804 |
| 58 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.96036256 |
| 59 | Olfactory transduction_Homo sapiens_hsa04740 | 0.94508730 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93542560 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.92587743 |
| 62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.91562357 |
| 63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.91304532 |
| 64 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.90344550 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.90211254 |
| 66 | Insulin secretion_Homo sapiens_hsa04911 | 0.89235325 |
| 67 | Morphine addiction_Homo sapiens_hsa05032 | 0.88429868 |
| 68 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.87195386 |
| 69 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.86356628 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83747263 |
| 71 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.82954095 |
| 72 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.78225128 |
| 73 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.76705233 |
| 74 | Measles_Homo sapiens_hsa05162 | 0.76118764 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.75444921 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73527473 |
| 77 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72382141 |
| 78 | Cell cycle_Homo sapiens_hsa04110 | 0.66699606 |
| 79 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.66232316 |
| 80 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.65987821 |
| 81 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.65773792 |
| 82 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65468495 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.64995643 |
| 84 | Alcoholism_Homo sapiens_hsa05034 | 0.63886854 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63628543 |
| 86 | Axon guidance_Homo sapiens_hsa04360 | 0.62326124 |
| 87 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.61921681 |
| 88 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.61828738 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60054338 |
| 90 | Circadian entrainment_Homo sapiens_hsa04713 | 0.59624922 |
| 91 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58564138 |
| 92 | Allograft rejection_Homo sapiens_hsa05330 | 0.58194817 |
| 93 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57615533 |
| 94 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.57071790 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56900617 |
| 96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55346656 |
| 97 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54515134 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54284653 |
| 99 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.53742114 |
| 100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52578589 |
| 101 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.52116139 |
| 102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51506156 |
| 103 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50348957 |
| 104 | Asthma_Homo sapiens_hsa05310 | 0.50128578 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48730122 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48321215 |
| 107 | Gap junction_Homo sapiens_hsa04540 | 0.47755008 |
| 108 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47672904 |
| 109 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46819710 |
| 110 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.46791180 |
| 111 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46230717 |
| 112 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46183132 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45974639 |
| 114 | Renin secretion_Homo sapiens_hsa04924 | 0.44900614 |
| 115 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.44477614 |
| 116 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.44472244 |
| 117 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.44061709 |
| 118 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43565137 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43289168 |
| 120 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.43113645 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43101598 |
| 122 | ABC transporters_Homo sapiens_hsa02010 | 0.42364862 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.40612334 |
| 124 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.39289871 |
| 125 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38231386 |
| 126 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38170096 |
| 127 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38110008 |
| 128 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.37862176 |
| 129 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.37094609 |
| 130 | Malaria_Homo sapiens_hsa05144 | 0.36247194 |
| 131 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.34364087 |
| 132 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.34113456 |
| 133 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.34057815 |
| 134 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33963127 |
| 135 | Cocaine addiction_Homo sapiens_hsa05030 | 0.33247290 |
| 136 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.33174386 |
| 137 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33047316 |
| 138 | Retinol metabolism_Homo sapiens_hsa00830 | 0.31006796 |
| 139 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.30920426 |
| 140 | RNA transport_Homo sapiens_hsa03013 | 0.29723357 |
| 141 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27524827 |
| 142 | GABAergic synapse_Homo sapiens_hsa04727 | 0.27227074 |
| 143 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.27171834 |
| 144 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.25448732 |
| 145 | Sulfur relay system_Homo sapiens_hsa04122 | 0.25368739 |
| 146 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.25271364 |
| 147 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.25270094 |
| 148 | Leishmaniasis_Homo sapiens_hsa05140 | 0.22795498 |

